Kyverna Therapeutics Inc. (KYTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kyverna Therapeutics Inc.

    NASDAQ: KYTX · Real-Time Price · USD
    5.52
    -0.56 (-9.21%)
    At close: Oct 03, 2025, 3:59 PM
    5.54
    0.36%
    After-hours: Oct 03, 2025, 07:59 PM EDT

    Kyverna Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 7.03M 5.66M
    Cost of Revenue
    		 2.13M 1.71M 1.05M 586K
    Gross Profit
    		 -2.13M -1.71M 5.97M 5.07M
    Operating Income
    		 -142.6M -62.41M -29.38M -26.35M
    Interest Income
    		 15.36M 2.28M 565K 1K
    Pretax Income
    		 -127.48M -60.37M -28.89M -26.35M
    Net Income
    		 -127.48M -60.37M -28.89M -26.35M
    Selling & General & Admin
    		 30.13M 12.48M 8.01M 6.15M
    Research & Development
    		 112.47M 49.92M 28.4M 25.85M
    Other Expenses
    		 -2.13M -55K -9K -2K
    Operating Expenses
    		 140.47M 62.41M 36.41M 32M
    Interest Expense
    		 142K 187K 65K 3K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 142.6M 62.41M 36.41M 32M
    Income Tax Expense
    		 n/a n/a 56K 1K
    Shares Outstanding (Basic)
    		 38.33M 673.62M 25.8M 25.8M
    Shares Outstanding (Diluted)
    		 38.33M 673.62M 25.8M 25.8M
    EPS (Basic)
    		 -3.33 -0.00 -1.12 -1.02
    EPS (Diluted)
    		 -3.33 -0.00 -1.12 -1.02
    EBITDA
    		 -125.2M -58.47M -27.78M -25.76M
    EBIT
    		 -127.33M -60.18M -28.83M -26.35M
    Depreciation & Amortization
    		 2.13M 1.71M 1.05M 586K

    Add to Watchlist